共 33 条
- [33] Tegaserod benefits patients with constipation predominant IBS (IBS-C) and delayed orocecal transit time (OCTT) as determined using the H2 lactulose breath test (LBT) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S332 - S332